Although dependent on individual coverage, several major insurers acknowledge semaglutide's medical necessity for weight management, potentially including policies from United Healthcare, Cigna, and Blue Cross Blue Shield varying by state and plan specifics
Sleep disturbances and insomnia have been reported by some users
The total number of lawsuits against glucagon-like peptide-1 (GLP-1) drug manufacturers, such as Novo Nordisk, has grown to nearly 2,200, with more cases being filed monthly
10.3390/foods11193000 35 LiM.WangS.LiY.ZhaoM.KuangJ.LiangD.et al (2022b)
When to Seek Medical Advice About Period Changes Whilst some menstrual variation during weight loss is common, certain changes warrant prompt medical evaluation
Surgery Cost is one of the biggest issues in the GLP-1 conversation